GATA1 mutational analysis in chronic myeloid leukaemia. 2007

Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias
D050982 GATA1 Transcription Factor A GATA transcription factor that is specifically expressed in hematopoietic lineages and plays an important role in the CELL DIFFERENTIATION of ERYTHROID CELLS and MEGAKARYOCYTES. Eryf1 Erythroid-Specific Transcription Factor,Erythroid Transcription Factor 1,Globin Transcription Factor 1,NF-E1 Erythroid-Specific Transcription Factor,Nuclear Factor-Erythroid 1,Transcription Factor GATA1,Transcription Factor NFE-1,Eryf1 Erythroid Specific Transcription Factor,Factor GATA1, Transcription,GATA1, Transcription Factor,NF E1 Erythroid Specific Transcription Factor,NFE-1, Transcription Factor,Nuclear Factor Erythroid 1,Transcription Factor, GATA1

Related Publications

Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
November 2003, British journal of haematology,
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
January 2020, IUBMB life,
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
June 1953, The British journal of radiology,
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
July 1954, Proceedings of the Royal Society of Medicine,
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
October 1956, The British journal of clinical practice,
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
April 2015, Lancet (London, England),
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
November 2021, Lancet (London, England),
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
January 1983, Nursing times,
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
December 1981, Australian and New Zealand journal of medicine,
Christina Halsey, and Chris Fisher, and Gordon Strathdee, and Brenda Gibson, and Tessa Holyoake, and Paresh Vyas, and Gerry Graham
July 2007, Lancet (London, England),
Copied contents to your clipboard!